Event Brief
Jun 22, 2026 at 7:06 PM ET
AbbVie to buy Apogee Therapeutics for $10.9B
By The BriefBrief
AbbVie agreed to acquire Apogee Therapeutics for $10.9 billion, a 49% premium over its June 18 close.
WHO: AbbVie
WHAT: Agreed to buy Apogee Therapeutics for $10.9 billion per $135.11 a share
WHEN: Jun 22, 2026 at 5:20 PM ET
WHERE: USA
WHY: To fund the acquisition with debt and pay a roughly 49% premium over Apogee’s June 18 closing price
Reporting from 2 identified publishers across this event arc.
View all 2 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Ukraine envoy warns it may modify ceasefire offer
Asia-Pacific
Jun 22, 2026 at 7:06 PM ET
Two more arrested in alleged plot to attack Trump UFC
Trump
Jun 22, 2026 at 7:06 PM ET
Colombia’s next president vows military push against traffickers
Americas
Jun 22, 2026 at 7:06 PM ET
Iran oil waiver offers lifeline as talks proceed
Middle-East
Jun 22, 2026 at 7:06 PM ET
Page 14883 of 21439
Same format. Every time.
Continue reading — sign in or create a free account with
